Board of Directors

Anders Ekblom
Chairman of the Board
    • Board member since: 2017
    • Independent in relation to the Company and its management: Yes
    • Independent in relation to major shareholders: Yes
    • Holdings in Alligator: 302,809 shares, 100,000 warrants in program TO 2022/2025 II, and 240,000 warrants in program TO 2023/2026 II.
    • Other current positions: Chairman of Atrogi AB, Elypta AB and Xspray Pharma AB. Board member of AnaMar AB and Mereo BioPharma Group plc
    Hans-Peter Ostler
    Vice chairman of the Board
      • Board member since: 2021
      • Independent in relation to the Company and its management: Yes
      • Independent in relation to major shareholders: Yes
      • Holdings in Alligator: 3,411,884 shares, 100,000 warrants in program TO 2022/2025 II, and 240,000 warrants in program TO 2023/2026 II.
      • Other current positions: Chairman of the Board in Ectin Research AB and Improve Tec Hönö AB, board member of RGNT Electric AB, Hoodin AB, Cinda Pharma, Promore Pharma, InorbitTX, S.P. HMSO AB, Oblique Therapeutics AB and Lennart Ekerholms Stiftelse. Deputy board member in O Mgmt AB.
      Graham Dixon
      Member of the Board
        • Board member since: 2019
        • Independent in relation to the Company and its management: Yes
        • Independent in relation to major shareholders: Yes
        • Holdings in Alligator: 240,000 warrants in program TO 2023/2026 II
        • Other current positions: Chairman of Apaxen BV
        Eva Sjökvist Saers
        Board member
          • Board member since: 2021
          • Independent in relation to the Company and its management: Yes
          • Independent in relation to major shareholders: Yes
          • Holdings in Alligator: 100,000 warrants in program TO 2022/2025 II and 240,000 warrants in program TO6.
          • Other current positions: Chairman of the board of Dicot AB (publ). Board member of Bluefish Pharmaceuticals AB (publ), IDL Biotech AB (publ), Oxcia AB and Apoex AB. Deputy board member of Brainstorm Aktiebolag.
          Veronica Wallin
          Board member
            • Board member since: 2021
            • Independent in relation to the Company and its management: Yes
            • Independent in relation to major shareholders: Yes
            • Holdings in Alligator: 101,550 shares, 100,000 warrants in program TO 2022/2025 II and 240,000 warrants in program TO 2023/2026 II.
            • Other current positions: Board member for a number of subsidiaries within the Episurf Group, Board member in IRLAB Therapeutics AB, Board member in Integrative Research Laboratories Sweden AB.
            Staffan Encrantz
            Board member
              • Board member since: 2022
              • Independent in relation to the Company and its management: Yes
              • Independent in relation to major shareholders: No
              • Holdings in Alligator: 205,840,049 shares.
              • Other current positions: Chairman of AnaMar AB, Sweden, a company engaged in the research and development of drugs for fibrosis, Koncentra AB, Sweden, a contract manufacturing group, Nclear Inc., Atlanta GA, a company in the water treatment business, Oxymetal SAS, France a laser and plasma steel cutting business and Sight Sciences Inc., Menlo Park CA, an eye care company developing and selling devices for surgical treatment of glaucoma and dry eye. Board member of KS Large Bore Pistons GmBH.
              Denise Goode
              Board member
                • Board member since: 2022
                • Independent in relation to the Company and its management: Yes
                • Independent in relation to major shareholders: Yes
                • Holdings in Alligator: 240,000 warrants in program TO 2023/2026 II
                • Other current positions: CEO of QED Life Sciences Limited, a consultancy company advising and supporting the strategic direction of biotech companies and providing business mentoring to CEOs and senior leaders. Board member of Abliva AB (publ) where she is chair of the remuneration committee and a member of the audit committee. VP, Business Development at AnaMar AB. Certified COVID vaccinator for the UK National Health Service.
                Anette Sundstedt
                Employee representative
                  • Board member since: 2023
                  • Independent in relation to the Company and its management: No
                  • Independent in relation to major shareholders: Yes
                  • Holdings in Alligator: 13,000 shares, 50,000 warrants in program TO 2022/2025 I, and 120,000 warrants in program TO 2023/2026 I.
                  About Alligator
                  Management
                  Career

                  Updated 2023-06-21
                  Cookies
                  We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our cookie policy.
                  Settings Accept all
                  Cookies
                  Do your settings below. Or read our cookie policy.
                  Save Accept all